These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38270775)

  • 21. An improved prognostic parameter for non-Hodgkin's lymphoma based on the combination of three serum tumor markers.
    Gui W; Wang T; Wang J; Wang L; He J; Yang B; Zhao Z; Zhang H; Zhang Q
    Int J Biol Markers; 2008; 23(4):207-13. PubMed ID: 19199267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low expression of dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin in non-Hodgkin lymphoma and a significant correlation with β2-microglobulin.
    Ding D; Chen W; Zhang C; Chen Z; Jiang Y; Yang Z; Jiang X; Zuo Y; Ren S
    Med Oncol; 2014 Oct; 31(10):202. PubMed ID: 25182705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new serologic index for low-grade non-Hodgkin's lymphoma based on initial CA125 and LDH serum levels.
    Benboubker L; Valat C; Linassier C; Cartron G; Delain M; Bout M; Fetissof F; Lefranq T; Lamagnere JP; Colombat P
    Ann Oncol; 2000 Nov; 11(11):1485-91. PubMed ID: 11142490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C-reactive protein serum level is a valuable and simple prognostic marker in non Hodgkin's lymphoma.
    Legouffe E; Rodriguez C; Picot MC; Richard B; Klein B; Rossi JF; Commes T
    Leuk Lymphoma; 1998 Oct; 31(3-4):351-7. PubMed ID: 9869199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multicenter retrospective analysis of 581 patients with primary intestinal non-hodgkin lymphoma from the Consortium for Improving Survival of Lymphoma (CISL).
    Kim SJ; Choi CW; Mun YC; Oh SY; Kang HJ; Lee SI; Won JH; Kim MK; Kwon JH; Kim JS; Kwak JY; Kwon JM; Hwang IG; Kim HJ; Lee JH; Oh S; Park KW; Suh C; Kim WS
    BMC Cancer; 2011 Jul; 11():321. PubMed ID: 21798075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of baseline peripheral absolute neutrophil, monocyte and serum β2-microglobulin level in patients with diffuse large b-cell lymphoma: a new prognostic model.
    Chen Y; Neelapu S; Feng L; Bi W; Yang TH; Wang M; Fanale MA; Westin JR; Hagemeister FB; Fayad LE; Romaguera JE; Samaniego F; Turturro F; Fowler NH; McLaughlin P; Cabanillas F; Oki Y; Nastoupil LJ; Rodriguez A
    Br J Haematol; 2016 Oct; 175(2):290-299. PubMed ID: 27448187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum CA125: a tumor marker for monitoring response to treatment and follow-up in patients with non-Hodgkin's lymphoma.
    Zidan J; Hussein O; Basher W; Zohar S
    Oncologist; 2004; 9(4):417-21. PubMed ID: 15266095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of serum beta 2 microglobulin in primary gastric lymphoma.
    Avilés A; Díaz-Maqueo JC; Rodriguez L; García EL; Guzmán R; Talavera A
    Hematol Oncol; 1991; 9(2):115-21. PubMed ID: 1869242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics of Central Nervous System (CNS) Involvement in Children With Non-Hodgkin's Lymphoma (NHL) and the Diagnostic Value of CSF Flow Cytometry in CNS Positive Disease.
    Huang S; Jin L; Yang J; Duan Y; Zhang M; Zhou C; Zhang YH
    Technol Cancer Res Treat; 2021; 20():15330338211016372. PubMed ID: 34060372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-hodgkin lymphoma and circulating markers of inflammation and adiposity in a nested case-control study: the multiethnic cohort.
    Conroy SM; Maskarinec G; Morimoto Y; Franke AA; Cooney RV; Wilkens LR; Goodman MT; Hernadez BY; Le Marchand L; Henderson BE; Kolonel LN
    Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):337-47. PubMed ID: 23300021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression of the neopterin in serum and urine of the patients with non-Hodgkin's lymphoma].
    Cheng XC; Li HC; Zhang R; Tan J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):443-6. PubMed ID: 15972138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beta-2 microglobulin predicts the outcome after autologous stem cell transplantation in non-Hodgkin lymphoma.
    Atesoglu EB; Hacıhanefioglu A; Gulbas Z
    Transfus Apher Sci; 2015 Feb; 52(1):65-71. PubMed ID: 25577449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CNS involvement in children with newly diagnosed non-Hodgkin's lymphoma.
    Sandlund JT; Murphy SB; Santana VM; Behm F; Jones D; Berard CW; Furman WL; Ribeiro R; Crist WM; Greenwald C; Chen G; Walter A; Pui CH
    J Clin Oncol; 2000 Aug; 18(16):3018-24. PubMed ID: 10944136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [BCL-2/IgH and IgH gene rearrangements in bone marrow mononuclear cells of patients with non-Hodgkin's lymphoma].
    Zhang XH; Liang Y; Wang GJ; Ruan EB; Fu R; Qu W; Liu H; Guan J; Song J; Wang HQ; Wu YH; Xing LM; Wang XM; Wang J; Li LJ; Shao ZH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):379-84. PubMed ID: 21518492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and prognostic analysis of 125 cases of non-Hodgkin's lymphoma.
    Liu L; Zhang M; Zou P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):547-50. PubMed ID: 18549626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum IL-6, IL-8, IL-10 and beta2-microglobulin in association with International Prognostic Index in diffuse large B cell lymphoma.
    Duletić-Nacinović A; Stifter S; Marijić B; Lucin K; Valković T; Petranović D; Jonjić N
    Tumori; 2008; 94(4):511-7. PubMed ID: 18822687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients.
    Warzocha K; Salles G; Bienvenu J; Bastion Y; Dumontet C; Renard N; Neidhardt-Berard EM; Coiffier B
    J Clin Oncol; 1997 Feb; 15(2):499-508. PubMed ID: 9053471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eight-year experience of malignant lymphoma--survival and prognostic factors.
    Hahn JS; Lee S; Chong SY; Min YH; Ko YW
    Yonsei Med J; 1997 Oct; 38(5):270-84. PubMed ID: 9409190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical value of combined detection of LDH, TPS, CEA and beta2-MG in patients with non- Hodgkin's lymphoma].
    Chen W; Luo RC; Fan WW; Ma SD
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Feb; 26(2):227-8, 230. PubMed ID: 16503538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum-soluble fas level determines clinical symptoms and outcome of patients with aggressive non-Hodgkin's lymphoma.
    Hara T; Tsurumi H; Takemura M; Goto H; Yamada T; Sawada M; Takahashi T; Moriwaki H
    Am J Hematol; 2000 Aug; 64(4):257-61. PubMed ID: 10911377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.